Interpreting Liver Function Tests: ALT Topical Map: SEO Clusters

ALT (alanine aminotransferase) is predominantly hepatocellular and rises when liver cells are injured; AST (aspartate aminotransferase) is found in liver but also muscle, heart, and red cells, so isolated AST elevations can be extrahepatic. A higher ALT than AST typically indicates primary liver injury, while patterns and ratios help narrow causes.

Compare transaminases (ALT/AST) with cholestatic markers (ALP, GGT, bilirubin): hepatocellular injury shows marked ALT/AST elevation with relatively normal ALP, whereas cholestatic injury shows predominant ALP and conjugated bilirubin elevation. Use R-value ([ALT/ULN] ÷ [ALP/ULN]) >5 for hepatocellular, <2 for cholestatic, and 2–5 for mixed patterns.

ALP rises with cholestasis, bone disease, pregnancy, and some cancers; if ALP is elevated, check GGT and bone-specific markers to confirm hepatic origin. If GGT is also high, pursue imaging for biliary obstruction; if GGT is normal, evaluate for bone or placental causes.

Unconjugated (indirect) bilirubin elevations suggest hemolysis, Gilbert syndrome, or impaired uptake, and are often benign if mild and stable; conjugated (direct) bilirubin elevation indicates hepatocellular cholestasis or biliary obstruction and warrants imaging and urgent workup if markedly elevated. Look at fractionation — a direct fraction >50% of total bilirubin in a jaundiced patient points to conjugated hyperbilirubinemia.

An AST/ALT ratio greater than 2:1 in the right clinical context (moderately elevated enzymes) strongly suggests alcoholic liver injury or alcoholic hepatitis, with reported high specificity in acute settings; however, confirm with history, PE, and other labs because cirrhosis and advanced fibrosis can also raise AST relative to ALT.

For mild ALT elevations (eg, <2–3× ULN) with no symptoms, repeat testing, review medications/alcohol, screen for viral hepatitis, check metabolic risk factors (BMI, diabetes), and calculate a noninvasive fibrosis score (FIB-4); if persistent or risk factors present, order hepatic ultrasound and consider hepatology referral for fibrosis assessment.

Yes — AST is abundant in muscle and rises after trauma or intense exercise, while hemolysis increases unconjugated bilirubin and can falsely raise AST/ALT in hemolyzed samples; always correlate with clinical history and check CK for muscle injury or a hemolysis index on the lab report.

Urgent referral or ED evaluation is warranted for signs of acute liver failure (INR ≥1.5 plus encephalopathy), rapidly rising transaminases (>10× ULN) especially with coagulopathy, very high direct bilirubin with cholangitis features, or suspected acute acetaminophen overdose. For subacute or chronic abnormalities without red flags, expedited outpatient hepatology referral is appropriate.

Different labs use variable reference ranges and methods (eg, isoenzymes for ALP, Jendrassik–Grof for bilirubin), which can alter ULN thresholds; always interpret values against the lab-specific reference and consider sex- and age-specific cutoffs (men have higher ALT ULN).

Transaminases and bilirubin track disease activity but correlate imperfectly with fibrosis; use them alongside noninvasive fibrosis scores (FIB-4, APRI), transient elastography, and imaging to stage disease and decide on treatment or surveillance strategies.